BRILINTA 90MG BOTTLE 180`S

Essential Support for Patients With Acute Coronary Syndrome

Brilinta 90mg Tablet is an effective antiplatelet medication designed to prevent blood clots in individuals dealing with acute coronary syndrome (ACS). This includes conditions such as unstable angina and myocardial infarction (heart attack). The active ingredient, Ticagrelor, works efficiently to reduce clot formation by inhibiting platelet aggregation, thereby lowering the risk of life-threatening cardiovascular complications.

Usage Guidance and Precautions

For optimal results and safety, adherence to prescribed dosages and medical advice is key when using Brilinta 90mg Tablet. If you are scheduled for surgery, including dental procedures, informing your healthcare provider about this medication is crucial. To minimize bleeding risks associated with the drug, it is typically advised to discontinue use five days before any surgical procedure. Your physician will provide further instructions tailored to your health needs.

Know the Risks and Stay Informed

Though Brilinta is highly effective, it is contraindicated for those with hypersensitivity or allergic reactions to its components. Side effects such as irregular breathing patterns—speeding up, slowing down, or encountering short pauses—may occur. If these or any unusual symptoms arise, consult your doctor promptly for evaluation and guidance. Your safety is always a priority.

Brilinta 90mg Tablet is a trusted solution for ACS patients seeking to prevent blood clots and manage their heart health effectively. Consult your healthcare provider today to discover if Brilinta is right for you.